Reston-based New Atlantic Ventures joined a handful of other venture investors in backing Truveris, a New York startup whose cloud-based platform helps drive down the cost to companies of providing prescription drug benefits.
NAV Fund, an existing investor, joined New Leaf Venture Partners, Tribeca Venture Partners and First Round in Truveris’ $12.75 million Series C round, which was led by Canaan Partners.
{iframe}http://www.bizjournals.com/washington/blog/techflash/2014/06/new-atlantic-ventures-bets-on-pharmacy-tech.html{/iframe}